An international team, including astronomers from Keele University, has performed a unique cosmic test to measure the mass of ...

When white dwarfs—the hot remnants of stars like our sun—are orbited closely by another star, they sometimes steal mass away ...

Astronomers have spotted centimeter-sized “pebbles” swirling around two infant stars 450 light-years away, revealing the raw ...

Some of these open clusters are pretty famous, such as the Pleiades cluster, also known as the Seven Sisters. This is ...

Astronomers have confirmed the third interstellar object on record is dashing through our solar system. Dubbed 3I/ATLAS, it ...

As the country marks Matariki, more iwi are turning their gaze to Puanga – a long-overlooked star at the heart of many ...

Rigel reported net income of $11.4 million, or $0.64 basic and $0.63 diluted per share, compared to a net loss of $8.2 million, or $0.47 basic and diluted per share, for the same period of 2024.

But in common envelope evolution, “the companion star is so large that its outer layers engulf the neutron star as well,” Lorimer said. “This acts as a brake on the whole binary system.” ...

Astronomers confirmed water ice in a young star system using JWST. Crystalline water ice was found in the debris disk of star HD 181327. The star is 23 million years old and located 155 light ...

Rigel Pharmaceuticals Q1 Highlights (Rigel Pharmaceuticals) Perhaps the most impressive item to highlight is that TAVALISSE brought home $28.5M in Q1, which was a 35% year-over-year increase.

Rigel (RIGL) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

Rigel Pharmaceuticals (RIGL) could be a solid choice for investors given its recent upgrade to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, which is ...